NIVF NewGenIvf Group Limited
Healthcare$0.78-23.05%ClosedMarket Cap: $446,174
As of 2026-05-26
Valuation
P/E (TTM)
0.07
PEG
0.00
P/B
0.02
P/S
0.21
EV/EBITDA
0.49
DCF Value
$-7.34
FCF Yield
-1096.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
23.7%
Operating Margin
-276.6%
Net Margin
338.2%
ROE
32.7%
ROA
28.0%
ROIC
-24.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $1.4M | 36.8% | $-5.0M | $-7.7M | $— | — |
| FY null | $4.7M | 20.2% | $-10.7M | $9.9M | $— | — |
| Q3 null | $1.3M | 9.2% | $-2.5M | $16.8M | $— | — |
| Q4 null | $1.3M | 42.3% | $-1.1M | $-108.0K | $— | — |
| FY null | $5.4M | 33.6% | $-1.2M | $-525.0K | $— | — |
| Q3 null | $1.5M | 44.1% | $216.3K | $-19.9K | $— | — |
| Q4 null | $1.5M | 13.0% | $-1.3M | $-955.0K | $— | — |
| FY null | $5.1M | 32.7% | $42.2K | $130.2K | $— | — |
| Q3 null | $0.00 | NaN% | $-377.7K | $127.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-367.0K | $85.5K | $— | — |
| Q1 null | $0.00 | NaN% | $-510.5K | $52.1K | $— | — |
| Q4 2022 | $0.00 | NaN% | $-115.6K | $474.4K | $52.79 | — |